SaNOtize has developed and patented (issued) a Nitric Oxide Releasing Solution platform technology to treat and prevent microbial infections, including drug resistant microbes. Target indications include treatment for strep throat, athlete's foot, infected wounds, diabetic foot ulcers, sinusitis, cold and flu and others.
With antibiotic resistance increasing in the world, SaNOtize's platform technology can help fight resistance and bring a new innovating solution to fight infections.
Company Details
- Employees
- 26
- Founded
- 2017
- Address
- 8755 Ash St, Vancouver,british Columbia V6p 6t3,canada
- in****@****ize.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- sanotize.com
- Keywords
- Baton Rouge.
- HQ
- Vancouver, British Columbia
Sanotize Research And Development Corp. Questions
Sanotize Research And Development Corp.'s website is sanotize.com
Sanotize Research And Development Corp.'s LinkedIn profile is https://ca.linkedin.com/company/sanotize-research-and-development-corp
Sanotize Research And Development Corp. has
26 employees.
View email and phone details for 26
employees at Sanotize Research And Development Corp..
Sanotize Research And Development Corp.'s industry is
Biotechnology Research
Sanotize Research And Development Corp.'s top competitors are
Sanotize,
Abcellera,
Agilify Solutions Inc.,
Windtree Therapeutics, Inc.,
Stemcell Technologies,
Impres,
Vyne Therapeutics Inc.,
Agilify,
Phathom Pharmaceuticals,
Nowonder, Inc..
Sanotize Research And Development Corp.'s support email address is info@saNOtize.com
Sanotize Research And Development Corp.'s categories are Biotechnology Research
Sanotize Research And Development Corp.'s founding year is 2017
